Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > GTXI > Summary

GTX Inc.
(GTXI)

4.16USD   Up0.04 (0.97%)   
At 2:30AM IST
 GTX Inc. (NGM:GTXI) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 4.16USD
Trade Time:2:30AM IST
Change:Up0.04 (0.97%)
Prev Close:4.12
Open:4.15
Bid:4.05 x 500
Ask:4.86 x 100
1y Target Est:4.00
Day's Range:4.12 - 4.21
52wk Range:3.22 - 13.59
Volume:76,807
Avg Vol (3m):379,086
Market Cap:151.51M
P/E (ttm):N/A
EPS (ttm):-1.35
Div & Yield:N/A (N/A%)
Add GTXI to Portfolio   Download Data

HEADLINES

 
•This Week's Failed Trials, Missed Targets in Biotech - Seeking Alpha  - Sun, Dec 20
•Movers roundup: Waste Services, GTx - AP  - Tue, Dec 15
•GTx shares fall after delay leads to job cuts - AP  - Tue, Dec 15
•GTx Announces Reduction in Force - Business Wire  - Sat, Dec 12
•GTX INC /DE/ Financials - EDGAR Online Financials  - Fri, Nov 13
•GTx, Inc. Earnings Call scheduled for 9:00 am ET today - CCBN  - Mon, Nov 9
•GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition - EDGAR Online  - Mon, Nov 9
•3 Stocks Attracting Top Investors - Motley Fool  - Wed, Nov 4
•Hemispherx Cops to Ampligen FDA Delay - TheStreet.com  - Tue, Nov 3
•GTx shares crater on FDA rejection - MarketWatch  - Mon, Nov 2
•YRC Worldwide, LDK Solar: Midday Volume Plays - TheStreet.com  - Mon, Nov 2
» More Headlines for GTXI...

ANALYST

 
EPS Est (next year) (Dec-09) :-1.33
EPS Est (in 2 years) (Dec-10) :-0.88
Avg Rec (current)*:3.3
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules to treat cancer, osteoporosis and bone loss, muscle loss, and other serious medical conditions in the United States.

» Full Company Profile